S132: UPDATED RESULTS OF VEN-A-QUI STUDY: A PHASE 1-2 TRIAL TO ASSESS THE SAFETY AND EFFICACY OF TRIPLETS FOR NEWLY DIAGNOSED UNFIT AML PATIENTS: AZACITIDINE OR LOW-DOSE CYTARABINE...

por Miguel Bergua Burgues, Juan, Rodríguez-Veiga, Rebeca, Cano Ferri, Isabel, Vall-Llovera Calmet, Ferran, Garcia-Guiñon, Antonio, Gomez Espuch, Joaquin, Colorado, Mercedes, Casas-Avilés, Ignacio, Esteve, Jordi, Sampol, Antonia, Victoria Verdugo, Maria, Ramos, Fernando, Valero, Marta, Gloria Acuña Cruz, Evelyn, Boluda, Blanca, Torres Miñana, Laura, Martinez-Lopez, Joaquín, Barragan, Eva, Ayala Diaz, Rosa, Martinez-Cuadrón, David, Montesinos, Pau
Publicado 2023

P1147: FEASIBILITY AND OUTCOME AFTER DOSE REDUCTION OF IMMUNOCHEMOTHERAPY IN YOUNG ADULTS WITH BURKITT LYMPHOMA AND LEUKEMIA. RESULTS OF THE BURKIMAB14 TRIAL

por Maria Ribera, Josep, Morgades, Mireia, García-Calduch, Olga, Sirvent, Maialen, Buendía Ureña, Buenaventura, Cervera, Marta, Luzardo, Hugo, Hernández Rivas, Jesus, Sitges Arriaga, Marta, Garcia Cadenas, Irene, Abrisquet Acosta, Pablo, Montesinos, Pau, Bastos Oreiro, Mariana, Queipo de Llano, María-Paz, Bravo, Pilar, Torrent, Anna, Puente, Maria Pilar Herrera, Garcia-Guiñon, Antonio, Vall-Llovera Calmet, Ferran, Serrano, Josefina, Terol, Maria J, Burgues, Juan Miguel Bergua, García-Noblejas, Ana, Barrenetxea, Cristina, Llorente, Laura, García-Belmonte, Daniel, Gimeno, Eva, Cladera, Antonia, Mercadal Vilchez, Santiago, Manuel Sancho, Juan
Publicado 2023